• 9/22/25

Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter

Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources

Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development

You Might Also Like

Related Video Item Thumbnail Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development
Related Video Item Thumbnail Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories
Related Video Item Thumbnail Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development
Related Video Item Thumbnail Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs
Related Video Item Thumbnail Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials